trifluperidol has been researched along with Parkinsonian Disorders in 2 studies
Trifluperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p621)
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DIPIAZZA, P | 1 |
GORI, EC | 1 |
LEVI-MINZI, S | 1 |
O'REILLY, PO | 1 |
O'REGAN, JB | 1 |
LIOANAG, EM | 1 |
2 other studies available for trifluperidol and Parkinsonian Disorders
Article | Year |
---|---|
[CLINICAL EXPERIMENTATION WITH TRIPERIDOL].
Topics: Biomedical Research; Electromyography; Extrapyramidal Tracts; Hallucinations; Humans; Mental Disorde | 1963 |
TRIPERIDOL (A PRELIMINARY REPORT).
Topics: Adolescent; Biomedical Research; Geriatrics; Mental Disorders; Parasympatholytics; Parkinsonian Diso | 1964 |